According to eFFECTOR Therapeutics's latest financial reports the company's current EPS (TTM) is -11,67ย โฌ. In 2023 the company made an earnings per share (EPS) of -15,10ย โฌ a decrease over its 2022 EPS that were of -12,05ย โฌ.